Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DiSCo MRI SFN

Financiado

Developing Integrated Susceptibility and Conductivity MRI for Next Generation St...

Developing Integrated Susceptibility and Conductivity MRI for Next Generation Structural and Functional Neuroimaging MRI is indispensable in the diagnosis of neurodegenerative diseases. These are poorly understood while their prevalence and socio-economic burden continue to rise. Structural and functional MRI can provide biomarkers for early dia... ver más

30/09/2025

UNIVERSITY COLLEGE...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-10-31

ERC-2017-COG: ERC Consolidator Grant

I+D

Cerrada hace 7 años

0% 100% 100%

2 Participantes

UNIVERSITY COLLEGE LONDON

1.72M€ | Lider

SOCIEDAD ANONIMA SISTEL

368.34K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TEC2009-14587-C03-01 NEUROBIN: BIOMARCADORES DE NEUROIMAGEN PARA ENFERMEDADES NEU... 108K€ Cerrado

TEC2013-44194-P DESARROLLO DE BIOMARCADORES CLINICOS CON RESONANCIA MAGNETIC... 285K€ Cerrado

TEC2009-14587-C03-02 BIOMARCADORES DE NEUROIMAGEN EN ENFERMEDADES NEURODEGENERATI... 70K€ Cerrado

TEC2012-39095-C03-01 BIOMARCADORES BASADOS EN IMAGEN DE RESONANCIA MAGNETICA EN E... 183K€ Cerrado

EQC2021-007677-P Magnetoencefalografia 2K€ Cerrado

BFU2015-64380-C2-2-R ANALISIS DE TEXTURAS EN IMAGEN CEREBRAL MULTIMODAL POR RESON... 127K€ Cerrado

Duración del proyecto: 82 meses Fecha Inicio: 2018-10-31
Fecha Fin: 2025-09-30

Líder del proyecto

UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto MRI is indispensable in the diagnosis of neurodegenerative diseases. These are poorly understood while their prevalence and socio-economic burden continue to rise. Structural and functional MRI can provide biomarkers for early diagnosis and potential therapeutic intervention. My research vision is to develop novel MRI methods for structural and functional mapping of tissue magnetic susceptibility and electrical conductivity as these show great promise for neuroimaging in diseases such as Alzheimer’s (AD). Susceptibility mapping (SM), which I pioneered, is uniquely sensitive to tissue composition including iron content affected in AD while conductivity mapping (CM) probably reflects cellular disruption in AD. Resting-state functional MRI (rsfMRI) reveals how AD affects brain networks without any tasks or stimulation equipment. However, each technique currently needs a separate time-consuming MRI scan. I will develop an integrated scan for simultaneous structural SM and CM, and rsfMRI functional connectivity characterisation. This efficient scan, ideal for AD patients, will reveal totally new resting-state networks based on electromagnetic properties: resting-state functional SM and resting-state functional CM for the first time. As changes in blood susceptibility underlie fMRI, rsfSM should measure functional connectivity more directly. This also makes it sensitive to physiological noise so I will develop noise removal methods building on fMRI techniques I established. Initial fSM studies have been at 7 Tesla but I will target the more widespread 3T field to maximise applicability. As a leader in both SM and rsfMRI physiological noise removal I have the ideal background to integrate SM and CM with fMRI and extend them for ground-breaking functional electromagnetic connectivity. This research will yield a rich set of novel, multimodal MRI contrasts to allow development of new combined structural and functional biomarkers for early diagnosis of AD and other diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores